title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients - AC Immune  ( NASDAQ:ACIU ) ,20241114T153249,https://www.benzinga.com/general/biotech/24/11/41977487/ac-immunes-active-immunotherapy-shows-antibody-responses-in-early-parkinsons-patients,TAK,0.215894,Neutral,0.062964
"Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday? - AC Immune  ( NASDAQ:ACIU ) , Takeda Pharmaceutical  ( NYSE:TAK ) ",20240513T174629,https://www.benzinga.com/general/biotech/24/05/38797408/why-is-small-cap-alzheimers-focused-ac-immune-stock-trading-higher-on-monday,TAK,0.240489,Neutral,0.068487
"AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease - AC Immune  ( NASDAQ:ACIU ) , Takeda Pharmaceutical  ( NYSE:TAK ) ",20240513T100000,https://www.benzinga.com/pressreleases/24/05/g38783373/ac-immune-and-takeda-sign-exclusive-option-and-license-agreement-for-active-immunotherapy-targetin,TAK,0.035875,Neutral,0.032077
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease,20240513T100000,https://www.globenewswire.com/news-release/2024/05/13/2880195/0/en/AC-Immune-and-Takeda-Sign-Exclusive-Option-and-License-Agreement-for-Active-Immunotherapy-Targeting-Amyloid-Beta-for-Alzheimer-s-Disease.html,TAK,0.018743,Neutral,0.017806
Stocks That Hit 52-Week Lows On Monday,20220613T161842,https://www.benzinga.com/markets/options/22/06/27677156/52-weeks-high-and-low-article,TAK,0.005366,Neutral,-0.020459
